NCT00796965View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2008

Study Completion Date

March 31, 2009

Conditions
Healthy Volunteer
Interventions
DRUG

AZD7268

Solution/Capsule, Oral, once daily

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Philadelphia

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY